databahn

Johnson & Johnson Fortune 500 TURBO Report

Sale price Price $ 650.00 Regular price

Johnson & Johnson logo

Johnson & Johnson Fortune 500 TURBO Report

Last updated: October 17, 2019

Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
Phone: (732)-524-0400
Website: http://www.jnj.com
Sector: Healthcare
Industry: Drug Manufacturers - Major
Full Time Employees: 135,100

The Johnson & Johnson  TURBO Report was researched and developed with the IT sales executive and the IT marketer in mind. Our goal is simple; eliminate the costly research time and help you identify new sales revenue opportunities.

Top 10 reasons to buy the Johnson & Johnson databahn TURBO company profile report:

  1. Create a better and more informed RFP Response proposal
  2. Brief your C-level executives before a sales call
  3. Eliminate the time it takes to build a strategic account plan
  4. Develop more effective account based marketing (ABM) programs
  5. Discover sales opportunities you're not aware of
  6. Understand the competitive landscape in the account
  7. Ramp up new sales reps faster in new accounts
  8. Need accurate contact information & org charts
  9. Insights into IT projects & initiatives
  10. Expand footprint in existing large enterprise accounts

Some of the insights & detailed information you can expect to see in the Johnson & Johnson databahn TURBO Report:

  • Comprehensive Business Description
  • Latest Earnings Call Highlights from the CEO
  • Accurate Contacts for the Executive Leadership Team and Board of Directors
  • Detailed Org Charts on corporate structure, board of directors, and the executive leadership team
  • Hand curated content from selected articles, interviews, case studies, and success stories (representing dozens of hours of research)
  • Technology Executive Insights to existing IT & telecom systems, projects, initiatives, and internal code names for applications, systems, and IT business units
  • Insights gleaned from technology related job descriptions
  • Important excerpts and highlights from the Annual Report (10-K)

Available for download now!


JOHNSON & JOHNSON EXECUTIVE LEADERSHIP

NAME TITLE COMPANY EMAIL
Alex Gorsky Chairman, Board of Directors and CEO Johnson & Johnson *****@jnj.com
Ashley McEvoy Executive Vice President, Worldwide Chairman, Medical Devices Johnson & Johnson *****@jnj.com
Jennifer Taubert Executive Vice President, Worldwide Chairman, Pharmaceuticals Johnson & Johnson *****@jnj.com
Joaquin Duato Vice Chairman of the Executive Committee Johnson & Johnson *****@jnj.com
Joseph J. Wolk Executive Vice President, CFO Johnson & Johnson *****@jnj.com
Kathy Wengel Executive Vice President & Chief Global Supply Chain Officer Johnson & Johnson *****@jnj.com
Michael Sneed Executive Vice President, Global Corporate Affairs & Chief Communication Officer Johnson & Johnson *****@jnj.com
Michael Ullmann Executive Vice President, General Counsel Johnson & Johnson *****@jnj.com
Paul Stoffels Vice Chairman of the Executive Committee and Chief Scientific Officer Johnson & Johnson *****@jnj.com
Peter Fasolo Executive Vice President, Chief Human Resources Officer Johnson & Johnson *****@jnj.com
Thibaut Mongon Executive Vice President, Worldwide Chairman, Consumer Johnson & Johnson *****@jnj.com



JOHNSON & JOHNSON BOARD OF DIRECTORS

NAME TITLE COMPANY EMAIL
A. Eugene Washington Duke University’s Chancellor for Health Affairs; President and CEO, Duke University Health System Johnson & Johnson *****@jnj.com
Alex Gorsky Chairman, Board of Directors and CEO Johnson & Johnson *****@jnj.com
Anne M. Mulcahy Former Chairman and CEO, Xerox Corporation Johnson & Johnson *****@jnj.com
Charles Prince Retired Chairman and CEO, Citigroup Inc. Johnson & Johnson *****@jnj.com
D. Scott Davis Former Chairman and CEO, United Parcel Service, Inc. Johnson & Johnson *****@jnj.com
Ian E. L. Davis Chairman, Rolls-Royce Holdings plc; Former Chairman and Worldwide Managing Director, McKinsey & Company Johnson & Johnson *****@jnj.com
Jennifer A. Doudna Professor of Chemistry; Professor of Biochemistry & Molecular Biology; Li Ka Shing Chancellor's Professor in Biomedical and Health, University of California, Berkeley Johnson & Johnson *****@jnj.com
Marillyn A. Hewson Chairman, President and CEO, Lockheed Martin Corporation Johnson & Johnson *****@jnj.com
Mark B. McClellan Director, Duke-Robert J. Margolis, MD, Center for Health Policy Johnson & Johnson *****@jnj.com
Mary C. Beckerle CEO, Huntsman Cancer Institute at the University of Utah; Distinguished Professor of Biology, College of Science, University of Utah Johnson & Johnson *****@jnj.com
Ronald A. Williams Former Chairman and CEO, Aetna Inc. Johnson & Johnson *****@jnj.com
William D. Perez Retired President and CEO, Wm. Wrigley Jr. Company Johnson & Johnson *****@jnj.com

 

7 KEYS TO OPEN DOORS AT JOHNSON & JOHNSON

Johnson and Johnson is expanding its Jacksonville, FL manufacturing facility

  • Johnson & Johnson Vision manufactures its ACUVUE contact lenses at the 732,000-sq.-ft. facility in Baymeadows.
  • Site plans show the company wants to add about 15,000 sq. ft. to its central utility plant on the 69-acre site, and it has more space allocated for a “future generator” and “future expansion.”


Johnson and Johnson Automates 95% of their Compliance Training Process

  • "We train around 120,000 people on annual compliance training each year. When thinking about the follow-up scale for that amount of people when you're trying to get to a 95,000-completion rate, it gets a little bit complicated unless you have a really good way to organize it and get people to access to that information in an easy way.” – Adam Ehrenworth, Lead Technology Analyst
  • The working solution Alteryx has a touchpoint in all four of the training cycles now, which are: Audience Identification, Tracking Completions, Follow Up with Users, Metrics/Analysis


Johnson and Johnson is investing €100m in a Limerick, Ireland Expansion

  • Around 100 new jobs are to be created in Limerick, as Johnson & Johnson is to invest €100m as part of an expansion.
  • Johnson & Johnson Vision Care (Ireland) will be adding the new roles as part of the expansion to its manufacturing operations in the National Technology Park at Plassey.


Johnson and Johnson acquired Auris Health (a Silicon Valley surgical-robotics startup) for $3.4 billion

  • "In this new era of health care, we're aiming to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer" – Ashley McEvoy, the executive vice president of medical devices at J&J


Johnson and Johnson turns to Amazon Web Services

  • The IT division of the global enterprise turned to Amazon Web Services (AWS) when it decided to move to the cloud and redefine its global IT strategy.
  • The company currently leverages the AWS Cloud to run 120 applications and for its big data architecture allowing it to complete highly intensive and complex data modeling.
  • Next, the company plans to triple the number of applications it hosts on AWS and launch 25,000 Amazon Workspaces cloud-based desktops for its consultants and employees to use around the globe.


Johnson & Johnson Creates an Intelligent Supply Chain

  • "I think another important factoid would be that, of the thousands and tens of thousands of employees, over half are in supply chain, so over 60,000 employees just in supply chain alone globally at J&J. I'm responsible for this advanced planning function within supply chain, that innovation aspect of it, in all of our divisions.” – Senior Director, Global Supply Chain Advanced Planning, Johnson and Johnson
  • “We also have a responsibility to teach the world that supply chain is core to what is happening here, and so that's why we're so excited to talk about it.”


Johnson and Johnson Cloud Engineering Team

  • The Cloud Engineering team, located in Raritan, NJ is building next generation hybrid cloud infrastructure for Johnson & Johnson globally.